615 related articles for article (PubMed ID: 18723958)
1. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
3. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.
Biswas B; Adhya S; Washart P; Paul B; Trostel AN; Powell B; Carlton R; Merril CR
Infect Immun; 2002 Jan; 70(1):204-10. PubMed ID: 11748184
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
Abd El-Aziz AM; Elgaml A; Ali YM
J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
[TBL] [Abstract][Full Text] [Related]
7. A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa.
Alvi IA; Asif M; Ur Rehman S
Virus Res; 2021 Jan; 292():198250. PubMed ID: 33259872
[TBL] [Abstract][Full Text] [Related]
8. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.
Vieira A; Silva YJ; Cunha A; Gomes NC; Ackermann HW; Almeida A
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3241-9. PubMed ID: 22777594
[TBL] [Abstract][Full Text] [Related]
9. Experimental protection of diabetic mice against Lethal P. aeruginosa infection by bacteriophage.
Shivshetty N; Hosamani R; Ahmed L; Oli AK; Sannauallah S; Sharanbassappa S; Patil SA; Kelmani CR
Biomed Res Int; 2014; 2014():793242. PubMed ID: 24999476
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
Yang M; Du C; Gong P; Xia F; Sun C; Feng X; Lei L; Song J; Zhang L; Wang B; Xiao F; Yan X; Cui Z; Li X; Gu J; Han W
Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
[TBL] [Abstract][Full Text] [Related]
12. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model.
Prokopczuk FI; Im H; Campos-Gomez J; Orihuela CJ; Martínez E
mBio; 2023 Jun; 14(3):e0047223. PubMed ID: 37039641
[TBL] [Abstract][Full Text] [Related]
13. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
15. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
16. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
17. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
[TBL] [Abstract][Full Text] [Related]
18. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
20. Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions.
Latz S; Krüttgen A; Häfner H; Buhl EM; Ritter K; Horz HP
Viruses; 2017 Oct; 9(11):. PubMed ID: 29077053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]